Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

CPMP opinion favors approval of Glaxo Wellcome's Ziagen

March 29, 1999

New Sustiva clinical data reported at European congress

March 29, 1999

Halving dose of Preveon does not reduce its efficacy in HIV

March 29, 1999

Combination therapy with delavirdine and zidovudine in AIDS

March 18, 1999

In vivo function, migration of CTLs in HIV immunotherapy

March 17, 1999

HIV protease-activated Casp3 protein specifically targets infected cells

March 17, 1999

New AZT derivatives with improved anti-HIV activity presented by Hughes Institute

March 16, 1999

Hollis-Eden to initiate HIV/AIDS trials with HE-2000 in South Africa

March 15, 1999

Procept's PRO-2000 Gel shows positive results in protection from HIV infection

March 12, 1999

Improved non-nucleoside HIV-1 RT inhibitors in development at Boehringer Ingelheim

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...